S&P 500   4,293.93
DOW   33,833.61
QQQ   353.15
High Dividend REITs: Are They an Ideal Way to Diversify?
Having Trouble in Your Trading? (Ad)
Stock market today: Asian shares mostly rise, lifted by bull market on Wall Street
2 Dow Stocks Trading Less Than 10x Earnings are Blue Chip Values
Having Trouble in Your Trading? (Ad)
Boost for homebuyers: Average long-term US mortgage rate eases from 7-month high to 6.71% this week
6 Best Online and Direct Marketing Retail Stocks to Invest in
[BREAKING] New "Living Software" to Revolutionize Warfare (Ad)
Homebuilding Stocks Defying Cooling Housing Market: Time to Sell?
The S&P 500 is in a bull market. Here's what that means and how long the bull might run
S&P 500   4,293.93
DOW   33,833.61
QQQ   353.15
High Dividend REITs: Are They an Ideal Way to Diversify?
Having Trouble in Your Trading? (Ad)
Stock market today: Asian shares mostly rise, lifted by bull market on Wall Street
2 Dow Stocks Trading Less Than 10x Earnings are Blue Chip Values
Having Trouble in Your Trading? (Ad)
Boost for homebuyers: Average long-term US mortgage rate eases from 7-month high to 6.71% this week
6 Best Online and Direct Marketing Retail Stocks to Invest in
[BREAKING] New "Living Software" to Revolutionize Warfare (Ad)
Homebuilding Stocks Defying Cooling Housing Market: Time to Sell?
The S&P 500 is in a bull market. Here's what that means and how long the bull might run
S&P 500   4,293.93
DOW   33,833.61
QQQ   353.15
High Dividend REITs: Are They an Ideal Way to Diversify?
Having Trouble in Your Trading? (Ad)
Stock market today: Asian shares mostly rise, lifted by bull market on Wall Street
2 Dow Stocks Trading Less Than 10x Earnings are Blue Chip Values
Having Trouble in Your Trading? (Ad)
Boost for homebuyers: Average long-term US mortgage rate eases from 7-month high to 6.71% this week
6 Best Online and Direct Marketing Retail Stocks to Invest in
[BREAKING] New "Living Software" to Revolutionize Warfare (Ad)
Homebuilding Stocks Defying Cooling Housing Market: Time to Sell?
The S&P 500 is in a bull market. Here's what that means and how long the bull might run
S&P 500   4,293.93
DOW   33,833.61
QQQ   353.15
High Dividend REITs: Are They an Ideal Way to Diversify?
Having Trouble in Your Trading? (Ad)
Stock market today: Asian shares mostly rise, lifted by bull market on Wall Street
2 Dow Stocks Trading Less Than 10x Earnings are Blue Chip Values
Having Trouble in Your Trading? (Ad)
Boost for homebuyers: Average long-term US mortgage rate eases from 7-month high to 6.71% this week
6 Best Online and Direct Marketing Retail Stocks to Invest in
[BREAKING] New "Living Software" to Revolutionize Warfare (Ad)
Homebuilding Stocks Defying Cooling Housing Market: Time to Sell?
The S&P 500 is in a bull market. Here's what that means and how long the bull might run
LON:OBD

Oxford BioDynamics (OBD) Share Forecast, Price & News

GBX 12.05
-1.40 (-10.41%)
(As of 06:05 AM ET)
Compare
Today's Range
12.05
▼
13.35
50-Day Range
13.48
▼
17.35
52-Week Range
10.98
▼
22.75
Volume
346,043 shs
Average Volume
225,406 shs
Market Capitalization
£17.68 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ProfileAnalyst RatingsChartCompetitorsInsider TradesHeadlines

OBD stock logo

About Oxford BioDynamics (LON:OBD) Stock

Oxford BioDynamics Plc, a biotechnology company, discovers and develops biomarkers for use in the pharmaceutical and biotechnology industry primarily in the United States and the United Kingdom. The company provides EpiSwitch, a proprietary technology platform that enables screening, evaluation, validation, and monitoring of 3D genomic biomarkers to diagnose patients. Its products include EpiSwitch CiRT (Checkpoint Inhibitor Response Test), a blood test for predicting therapeutic response to checkpoint inhibitor immunotherapy; EpiSwitch CST (Covid Severity Test), an advanced blood test for the prediction of COVID-19 severity in adults; and EpiSwitch Explorer Array Kit for high-resolution 3D genome profiling. Oxford BioDynamics Plc was incorporated in 2007 and is headquartered in Oxford, the United Kingdom.

Receive OBD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Oxford BioDynamics and its competitors with MarketBeat's FREE daily newsletter.

OBD Stock News Headlines

June 1, 2023 | americanbankingnews.com
Shore Capital Reaffirms "House Stock" Rating for Oxford BioDynamics (LON:OBD)
May 30, 2023 | marketwatch.com
Oxford BioDynamics Shares Fall on Wider 1H Loss, Need for More Cash
June 9, 2023 | Legacy Research (Affiliate) (Ad)
Sell Every Stock, Except ONE (Ticker Revealed)
We saw one of the longest bull markets in history, with the S&P surging well over 800% But now the chickens have come home to roost. However, Jeff Clark couldn’t care less because he ignores almost every single stock in the market.
May 2, 2023 | marketwatch.com
Oxford BioDynamics Receives $963,000 Award for Adverse Response Oncology Test
February 10, 2023 | msn.com
This blood test can detect prostate cancer with 94 percent accuracy
February 8, 2023 | msn.com
Scientists create ‘impressive’ new blood test for prostate cancer that is 94% accurate
February 7, 2023 | msn.com
New blood test for prostate cancer is 94% accurate, researchers say
February 2, 2023 | finance.yahoo.com
The Non-Executive Director of Oxford BioDynamics Plc (LON:OBD), Stephen Diggle, Just Bought A Few More Shares
June 9, 2023 | Legacy Research (Affiliate) (Ad)
Sell Every Stock, Except ONE (Ticker Revealed)
We saw one of the longest bull markets in history, with the S&P surging well over 800% But now the chickens have come home to roost. However, Jeff Clark couldn’t care less because he ignores almost every single stock in the market.
January 29, 2023 | finance.yahoo.com
Oxford BioDynamics Full Year 2022 Earnings: UK£0.067 loss per share (vs UK£0.072 loss in FY 2021)
December 19, 2022 | finance.yahoo.com
Oxford BioDynamics in San Francisco for the 41st Annual J.P. Morgan Healthcare Conference
December 16, 2022 | finance.yahoo.com
Massachusetts General Hospital Reports Results of Interim Analysis from REFINE-ALS Biomarker Trial by Mitsubishi Tanabe Pharma USA, Utilizing Oxford Biodynamics’ EpiSwitch® Platform for Prognostic Stratification of Fast Progression ALS
October 8, 2022 | fool.co.uk
Oxford BioDynamics
October 8, 2022 | finance.yahoo.com
Oxford BioDynamics (LON:OBD) Will Have To Spend Its Cash Wisely
October 7, 2022 | marketwatch.com
Oxford BioDynamics to Raise Up to GBP12 Mln to Boost Cancer Test Commercialization
June 28, 2022 | lse.co.uk
Oxford BioDynamics shares drop as it might need funding by early 2023
June 21, 2022 | barrons.com
Oxford BioDynamics's Checkpoint Inhibitor Response Test (EpiSwitch(R) CiRT) Now Available in the UK
March 11, 2022 | finance.yahoo.com
Oxford BioDynamics Plc (OBD.L)
November 22, 2021 | finance.yahoo.com
Is Oxford BioDynamics (LON:OBD) In A Good Position To Deliver On Growth Plans?
October 25, 2021 | marketwatch.com
Armistice Capital Invests GBP3.6 Mln in Oxford BioDynamics
August 31, 2021 | lse.co.uk
Geronimo the alpaca euthanised in Britain despite public outcry
August 31, 2021 | lse.co.uk
TRADING UPDATES: Jet2 in bumper Airbus order; Strix China factory live
August 31, 2021 | lse.co.uk
Ryanair predicts strong recovery, ups passenger target
August 31, 2021 | lse.co.uk
Oxford BioDynamics awarded $0.91m US PACT grant
August 31, 2021 | finance.yahoo.com
Oxford BioDynamics Awarded US FNIH Grant to Apply EpiSwitch® Immune Health Test for Improved Prediction of Patient Response to Immune Checkpoint Inhibitor (ICI) Cancer Therapies
July 29, 2021 | marketwatch.com
Genetic Testing Market is projected to manifest the fastest CAGR of 11.53% through 2027
July 27, 2021 | dailymail.co.uk
Pioneering blood test which tells Covid patients how severe their illness will be and gives a result in 15 minutes is approved for sale to UK hospitals
See More Headlines

OBD Price History

OBD Company Calendar

Last Earnings
6/16/2020
Today
6/09/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
LON
Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
Current Symbol
LON:OBD
CUSIP
N/A
CIK
N/A
Web
www.oxfordbiodynamics.com
Phone
+44-1865-518910
Fax
N/A
Employees
44
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
GBX (0.07)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
£-6,710,000.00
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-144.60%
Return on Assets
-40.23%

Debt

Debt-to-Equity Ratio
237.09
Current Ratio
0.95
Quick Ratio
2.80

Sales & Book Value

Annual Sales
£176,000.00
Price / Sales
112.12
Cash Flow
GBX 3.38 per share
Price / Cash Flow
3.98
Book Value
GBX 3 per share
Price / Book
4.48

Miscellaneous

Outstanding Shares
146,710,000
Free Float
N/A
Market Cap
£19.73 million
Optionable
Not Optionable
Beta
1.15

Key Executives

  • Dr. Jon Anthony Joseph Burrows B.Sc. (Age 60)
    M.Sc., Ph.D., CEO & Exec. Director
    Comp: $542.58k
  • Mr. Paul Leslie Stockdale F.C.A. (Age 48)
    M.A., CFO & Exec. Director
    Comp: $206.95k
  • Dr. Alexandre Akoulitchev M.A. (Age 61)
    Ma (Oxon), Ph.D., Chief Scientific Officer & Exec. Director
    Comp: $230.54k
  • Mr. Thomas G. Guiel B.A.
    Chief Operating Officer
  • Dr. Ewan Hunter B.Sc.
    BSC, Ph.D., Ph.D., (KCL), Chief Data Officer
  • T. Demain
    Company Sec.

Key Competitors

View All Competitors

Insiders

View All Insider Transactions













OBD Stock - Frequently Asked Questions

How have OBD shares performed in 2023?

Oxford BioDynamics' stock was trading at GBX 17.15 at the beginning of the year. Since then, OBD stock has decreased by 21.6% and is now trading at GBX 13.45.
View the best growth stocks for 2023 here.

How were Oxford BioDynamics' earnings last quarter?

Oxford BioDynamics Plc (LON:OBD) released its quarterly earnings data on Tuesday, June, 16th. The biotechnology company reported ($2.20) earnings per share for the quarter.

What other stocks do shareholders of Oxford BioDynamics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Oxford BioDynamics investors own include Oxford Biomedica (OXB), Frontline (FRO), Fate Therapeutics (FATE), Cargojet (CJT), China Unicom (Hong Kong) (CHU), Casey's General Stores (CASY), Buckle (BKE), Biffa (BIFF), AXT (AXTI) and Grupo Aval Acciones y Valores (AVAL).

What is Oxford BioDynamics' stock symbol?

Oxford BioDynamics trades on the London Stock Exchange (LON) under the ticker symbol "OBD."

How do I buy shares of Oxford BioDynamics?

Shares of OBD stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Oxford BioDynamics' stock price today?

One share of OBD stock can currently be purchased for approximately GBX 13.45.

How much money does Oxford BioDynamics make?

Oxford BioDynamics (LON:OBD) has a market capitalization of £19.73 million and generates £176,000.00 in revenue each year. The biotechnology company earns £-6,710,000.00 in net income (profit) each year or GBX (0.07) on an earnings per share basis.

How can I contact Oxford BioDynamics?

Oxford BioDynamics' mailing address is 26 Beaumont Street, OXFORD, OX1 2NP, United Kingdom. The official website for the company is www.oxfordbiodynamics.com. The biotechnology company can be reached via phone at +44-1865-518910.

This page (LON:OBD) was last updated on 6/9/2023 by MarketBeat.com Staff

My Account -